These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20018925)

  • 1. Multidrug resistance-associated protein 4 (MRP4) gene polymorphisms and treatment response in adult acute lymphoblastic leukemia.
    Brüggemann M; Trautmann H; Hoelzer D; Kneba M; Gökbuget N; Raff T
    Blood; 2009 Dec; 114(26):5400-1; author reply 5401-2. PubMed ID: 20018925
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia.
    Ansari M; Sauty G; Labuda M; Gagné V; Laverdière C; Moghrabi A; Sinnett D; Krajinovic M
    Blood; 2009 Aug; 114(7):1383-6. PubMed ID: 19515727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DPYD gene polymorphisms are associated with risk and chemotherapy prognosis in pediatric patients with acute lymphoblastic leukemia.
    Zhao XQ; Cao WJ; Yang HP; Yang XW; Tang P; Sun L; Gao X
    Tumour Biol; 2016 Aug; 37(8):10393-402. PubMed ID: 26846104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G80A Single Nucleotide Polymorphism in Reduced Folate Carrier-1 Gene in a Mexican Population and its Impact on Survival in Patients with Acute Lymphoblastic Leukemia.
    Candelaria M; Ojeda J; Gutiérrez-Hernández O; Taja-Chayeb L; Vidal-Millán S; Dueñas-González A
    Rev Invest Clin; 2016; 68(3):154-62. PubMed ID: 27409003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype.
    Steinbach D; Wittig S; Cario G; Viehmann S; Mueller A; Gruhn B; Haefer R; Zintl F; Sauerbrey A
    Blood; 2003 Dec; 102(13):4493-8. PubMed ID: 12816874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia.
    Valera ET; Scrideli CA; Queiroz RG; Mori BM; Tone LG
    Sao Paulo Med J; 2004 Jul; 122(4):166-71. PubMed ID: 15543372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance protein 4 (MRP4) polymorphisms impact the 6-mercaptopurine dose tolerance during maintenance therapy in Japanese childhood acute lymphoblastic leukemia.
    Tanaka Y; Manabe A; Fukushima H; Suzuki R; Nakadate H; Kondoh K; Nakamura K; Koh K; Fukushima T; Tsuchida M; Koike K; Kiyokawa N; Noguchi E; Sumazaki R; Komiyama T
    Pharmacogenomics J; 2015 Aug; 15(4):380-4. PubMed ID: 25403995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism in multidrug resistance-associated protein gene 3 is associated with outcomes in childhood acute lymphoblastic leukemia.
    Ansari M; Sauty G; Labuda M; Gagné V; Rousseau J; Moghrabi A; Laverdière C; Sinnett D; Krajinovic M
    Pharmacogenomics J; 2012 Oct; 12(5):386-94. PubMed ID: 21606946
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Byun JM; Koh Y; Shin DY; Kim I; Yoon SS; Lee JO; Bang SM; Kim KH; Jung SH; Lee WS; Park Y; Jang JH; Han JJ; Yhim HY; Kim DS; Lee YJ; Lee H; Choi YS; Lee S;
    Haematologica; 2017 May; 102(5):e187-e190. PubMed ID: 28082339
    [No Abstract]   [Full Text] [Related]  

  • 10. Ex vivo resistance in childhood acute lymphoblastic leukemia: Correlations between BCRP, MRP1, MRP4 and MRP5 ABC transporter expression and intracellular methotrexate polyglutamate accumulation.
    Jaramillo AC; Cloos J; Lemos C; Stam RW; Kaspers GJL; Jansen G; Peters GJ
    Leuk Res; 2019 Apr; 79():45-51. PubMed ID: 30849662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols.
    Motlló C; Ribera JM; Morgades M; Granada I; Montesinos P; Brunet S; Bergua J; Tormo M; García-Boyero R; Sarrà J; Del Potro E; Grande C; Barba P; Bernal T; Amigo ML; Grau J; Cervera J; Feliu E;
    Leuk Lymphoma; 2017 Jan; 58(1):145-152. PubMed ID: 27122129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCC4 functional SNP in the 3' splice acceptor site of exon 8 (G912T) is associated with unfavorable clinical outcome in children with acute lymphoblastic leukemia.
    Mesrian Tanha H; Rahgozar S; Mojtabavi Naeini M
    Cancer Chemother Pharmacol; 2017 Jul; 80(1):109-117. PubMed ID: 28550450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in GRIA1 gene are a risk factor for asparaginase hypersensitivity during the treatment of childhood acute lymphoblastic leukemia.
    Rajić V; Debeljak M; Goričar K; Jazbec J
    Leuk Lymphoma; 2015; 56(11):3103-8. PubMed ID: 25697915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial.
    Ribera JM; Oriol A; Morgades M; Montesinos P; Sarrà J; González-Campos J; Brunet S; Tormo M; Fernández-Abellán P; Guàrdia R; Bernal MT; Esteve J; Barba P; Moreno MJ; Bermúdez A; Cladera A; Escoda L; García-Boyero R; Del Potro E; Bergua J; Amigo ML; Grande C; Rabuñal MJ; Hernández-Rivas JM; Feliu E
    J Clin Oncol; 2014 May; 32(15):1595-604. PubMed ID: 24752047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia.
    Kourti M; Vavatsi N; Gombakis N; Sidi V; Tzimagiorgis G; Papageorgiou T; Koliouskas D; Athanassiadou F
    Int J Hematol; 2007 Aug; 86(2):166-73. PubMed ID: 17875533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD9 expression indicates a poor outcome in acute lymphoblastic leukemia.
    Liang P; Miao M; Liu Z; Wang H; Jiang W; Ma S; Li C; Hu R
    Cancer Biomark; 2018; 21(4):781-786. PubMed ID: 29286918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stanniocalcin1 gene expression in patients with acute leukemia: impact on response to therapy and disease outcome.
    Abaza HM; Elmougy MI; El Maraghy HM; Mahmoud HM
    Int J Lab Hematol; 2016 Feb; 38(1):81-9. PubMed ID: 26547904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol.
    Franca R; Rebora P; Bertorello N; Fagioli F; Conter V; Biondi A; Colombini A; Micalizzi C; Zecca M; Parasole R; Petruzziello F; Basso G; Putti MC; Locatelli F; d'Adamo P; Valsecchi MG; Decorti G; Rabusin M
    Pharmacogenomics J; 2017 Jan; 17(1):4-10. PubMed ID: 26644204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of -24CT, 1249GA, and 3972CT ABCC2 gene polymorphisms with methotrexate serum levels and toxic side effects in children with acute lymphoblastic leukemia.
    Sharifi MJ; Bahoush G; Zaker F; Ansari S; Rafsanjani KA; Sharafi H
    Pediatr Hematol Oncol; 2014 Mar; 31(2):169-77. PubMed ID: 24552501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute lymphoblastic leukemia in infants: a decade of experience in the Czech Republic.
    Jabali Y; Starý J; Hak J; Blazek B; Hrstkova H; Mihál V; Mydlil J; Timr P; Gajdos P
    Med Pediatr Oncol; 2000 Nov; 35(5):493-5. PubMed ID: 11070483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.